9 Meters Biopharma Inc.(NMTR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NMTR 9 Meters Biopharma Inc.

Delisted 11-15 19:28:11 EST

0.0722

+0.0000

0.00%

High0.0722	Low0.0722	Vol0.00
Open0.0722	D1 Closing0.0722	Amplitude0.00%
Mkt Cap1.04M	Tradable Cap920.60K	Total Shares14.46M
T/O0.00	T/O Rate0.00%	Tradable Shares12.75M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"NMTR","market":"US","secType":"STK","nameCN":"9 Meters Biopharma Inc.","latestPrice":0.0722,"timestamp":1731704400000,"preClose":0.0722,"halted":4,"volume":0,"delay":0,"floatShares":12750700,"shares":14459690,"eps":-3.526169,"marketStatus":"Delisted","change":0,"latestTime":"11-15 19:28:11 EST","open":0.0722,"high":0.0722,"low":0.0722,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.526169,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1731718800000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0722,"volumeRatio":0},"requestUrl":"/m/hq/s/NMTR/tweets","defaultTab":"tweets","newsList":[{"id":"2352728694","title":"Dow Jumps Over 300 Points; Morgan Stanley Posts Upbeat Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2352728694","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2352728694?lang=en_us&edition=fundamental","pubTime":"2023-07-19 00:23","pubTimestamp":1689697402,"startTime":"0","endTime":"0","summary":"U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 300 points on Tuesday.\n\nThe Dow traded up 1% to 34,932.08 while the NASDAQ rose 0.34% to 14,293.55. The S&amp;P 500, also rose, gaining, 0.46% to 4,543.70.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/23/07/33270822/dow-jumps-over-300-points-morgan-stanley-posts-upbeat-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCOM","MICS","LIXT","MS","BPTS","NMTR","ICAD","MASI"],"gpt_icon":0},{"id":"2352163745","title":"BRIEF-9 Meters Biopharma Inc And Units Files For Bankruptcy Protection","url":"https://stock-news.laohu8.com/highlight/detail?id=2352163745","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2352163745?lang=en_us&edition=fundamental","pubTime":"2023-07-18 20:43","pubTimestamp":1689684225,"startTime":"0","endTime":"0","summary":"July 18  - 9 Meters Biopharma Inc   :   * 9 METERS BIOPHARMA INC - ON JULY 17, CO WITH UNITS CEASED OPERATIONS AND FILED A VOLUNTARY PETITION FOR RELIEF UNDER BANKRUPTCY CODE   * 9 METERS BIOPHARMA INC - CONCURRENT WITH BANKRUPTCY FILING BETHANY SENSENIG, INTERIM CEO AND CFO, TENDERED HER RESIGNATION, EFFECTIVE JULY 17   * 9 METERS BIOPHARMA INC - AS OF JULY 17, 2023, CO HAS NO OFFICERS, CONSULTANTS OR EMPLOYEES   * 9 METERS BIOPHARMA - ON JULY 17, MARK SIRGO , MICHAEL CONSTANTINO, LORIN JOHNSON, MICHAEL RICE, SAMANTHA VENTIMIGLIA RESIGNED FROM BOARDFurther company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NMTR"],"gpt_icon":0},{"id":"2352574617","title":"BUZZ-9 Meters Biopharma slumps after filing for bankruptcy protection","url":"https://stock-news.laohu8.com/highlight/detail?id=2352574617","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2352574617?lang=en_us&edition=fundamental","pubTime":"2023-07-18 20:37","pubTimestamp":1689683837,"startTime":"0","endTime":"0","summary":"** Shares of drug developer 9 Meters Biopharma Inc    slump 70.2% to $0.18 premarket   ** NMTR says co and its units filed voluntary petitions for relief under Chapter 11 in the United States Bankruptcy Court for the District of North Carolina   ** Adds co received delisting notice from the Nasdaq and does not intend to appeal it     ** The assets of NMTR will be liquidated and claims paid in accordance with the Bankruptcy Code - SEC filing   ** The disclosure comes months after it said it was preparing to test an obesity drug candidate in human trials   ** Up to last close, NMTR shares down ~51% YTD ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","NMTR","BK4007"],"gpt_icon":0},{"id":"2352743679","title":"UPDATE 1-Drug developer 9 Meters Biopharma files for bankruptcy protection","url":"https://stock-news.laohu8.com/highlight/detail?id=2352743679","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2352743679?lang=en_us&edition=fundamental","pubTime":"2023-07-18 20:25","pubTimestamp":1689683122,"startTime":"0","endTime":"0","summary":"(Adds details on drug pipeline in paragraphs 2,3)      July 18 (Reuters) - Drug developer 9 Meters Biopharma  and its units have filed for Chapter 11 bankruptcy protection, it said in a regulatory fil","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NMTR"],"gpt_icon":0},{"id":"2344119279","title":"BRIEF-9 Meters Biopharma Gets Notice Of Delisting Or Failure From Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2344119279","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2344119279?lang=en_us&edition=fundamental","pubTime":"2023-06-17 04:50","pubTimestamp":1686948624,"startTime":"0","endTime":"0","summary":"June 16 (Reuters) - 9 Meters Biopharma Inc   :   * 9 METERS BIOPHARMA INC - ON JUNE 12, CO RECEIVED NOTICE OF DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD FROM NASDAQFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NMTR"],"gpt_icon":0},{"id":"2339861472","title":"9 Meters Biopharma slips 16% as CEO departs","url":"https://stock-news.laohu8.com/highlight/detail?id=2339861472","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2339861472?lang=en_us&edition=fundamental","pubTime":"2023-05-30 22:04","pubTimestamp":1685455478,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1296372105/image_1296372105.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1296372105/image_1296372105.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/3975823-9-meters-biopharma-stock-slips-ceo-departs","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["NMTR","BK4007","SBS","BK4172"],"gpt_icon":0},{"id":"2339004704","title":"9 Meters Biopharma Announces Management Change and Provides Clinical Update on Vurolenatide in Patients with Short Bowel Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2339004704","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2339004704?lang=en_us&edition=fundamental","pubTime":"2023-05-30 21:25","pubTimestamp":1685453100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/RCXeILW97jxa_piDrfIGzw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/efbf6a5a2f6d32c4de3ffe8ec60d7b94","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/RCXeILW97jxa_piDrfIGzw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/efbf6a5a2f6d32c4de3ffe8ec60d7b94"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/9-meters-biopharma-announces-management-132500126.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BK4172","NMTR","SBS"],"gpt_icon":0},{"id":"2337067329","title":"9 Meters Biopharma Inc - Co Submitted Plan Of Compliance To Nasdaq To Regain Compliance With Stockholders' Equity Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2337067329","media":"T-Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2337067329?lang=en_us&edition=fundamental","pubTime":"2023-05-22 20:54","pubTimestamp":1684760042,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.trkd.thomsonreuters.com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SANA","BK4588","QQQ","NQmain","BK4023","BK4585","QLD","APR","PSQ","CGEM",".IXIC","SQQQ","LHDX","EQR","NMTR","QID","BK4007","BK4082","BK4215","BK4196","ONTF","LABP","MNQmain","TQQQ"],"gpt_icon":0},{"id":"2336871455","title":"Maxim Group Keeps Their Hold Rating on 9 Meters Biopharma (NMTR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2336871455","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2336871455?lang=en_us&edition=fundamental","pubTime":"2023-05-18 22:35","pubTimestamp":1684420510,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-keeps-their-hold-rating-on-9-meters-biopharma-nmtr-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-keeps-their-hold-rating-on-9-meters-biopharma-nmtr-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMTR"],"gpt_icon":0},{"id":"2335982648","title":"9 Meters Biopharma Q1 EPS $(1.02) Misses $(0.78) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2335982648","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2335982648?lang=en_us&edition=fundamental","pubTime":"2023-05-16 13:08","pubTimestamp":1684213687,"startTime":"0","endTime":"0","summary":"9 Meters Biopharma (NASDAQ:NMTR) reported quarterly losses of $(1.02) per share which missed the analyst consensus estimate of $(0.78) by 30.77 percent. This is a 27.5 percent decrease over losses of $(0.80) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/23/05/32413993/9-meters-biopharma-q1-eps-1-02-misses-0-78-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMTR"],"gpt_icon":0},{"id":"2335812578","title":"9 Meters Biopharma GAAP EPS of -$1.02 misses by $0.24","url":"https://stock-news.laohu8.com/highlight/detail?id=2335812578","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2335812578?lang=en_us&edition=fundamental","pubTime":"2023-05-16 05:40","pubTimestamp":1684186812,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/3971794-9-meters-biopharma-gaap-eps-of-1_02-misses-0_24","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["NMTR","TQQQ","NQmain","BK4007","SQQQ",".IXIC","QLD","QQQ","QID","MNQmain","PSQ"],"gpt_icon":0},{"id":"2335812910","title":"9 Meters Biopharma Provides Business Update and Reports Financial Results  for First Quarter 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2335812910","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2335812910?lang=en_us&edition=fundamental","pubTime":"2023-05-16 05:15","pubTimestamp":1684185300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/RCXeILW97jxa_piDrfIGzw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/efbf6a5a2f6d32c4de3ffe8ec60d7b94","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/RCXeILW97jxa_piDrfIGzw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/efbf6a5a2f6d32c4de3ffe8ec60d7b94"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/9-meters-biopharma-provides-business-211500118.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BK4191","CRCT","TERN","WT","BK4539","NMTR"],"gpt_icon":0},{"id":"2330538055","title":"BRIEF-9 Meters Biopharma Enters Into Forbearance Agreement With Institutional Investor","url":"https://stock-news.laohu8.com/highlight/detail?id=2330538055","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2330538055?lang=en_us&edition=fundamental","pubTime":"2023-04-27 21:22","pubTimestamp":1682601747,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","SANA","BK4082","BK4196","CGEM","APR","LHDX","ONTF","LABP","NMTR","BK4023"],"gpt_icon":0},{"id":"2325396656","title":"9 Meters eyes FDA filing in H2 to start trial of obesity drug NM-136","url":"https://stock-news.laohu8.com/highlight/detail?id=2325396656","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2325396656?lang=en_us&edition=fundamental","pubTime":"2023-04-05 21:25","pubTimestamp":1680701105,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1367775811/image_1367775811.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1367775811/image_1367775811.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/3954667-9-meters-eyes-fda-filing-in-h2-start-trial-of-obesity-drug","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BK4021","BK4007","NMTR","NM"],"gpt_icon":0},{"id":"2325361488","title":"9 Meters Biopharma Announces Successful Pre-IND Meeting with FDA Regarding Its GIP Antagonist NM-136 for Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2325361488","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2325361488?lang=en_us&edition=fundamental","pubTime":"2023-04-05 20:00","pubTimestamp":1680696000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/RCXeILW97jxa_piDrfIGzw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/efbf6a5a2f6d32c4de3ffe8ec60d7b94","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/RCXeILW97jxa_piDrfIGzw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/efbf6a5a2f6d32c4de3ffe8ec60d7b94"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/9-meters-biopharma-announces-successful-120000147.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CRCT","NM","NMTR","BK4539","BK4021","BK4007","BK4191","TERN"],"gpt_icon":0},{"id":"2324057712","title":"Analysts Offer Insights on Healthcare Companies: Theriva Biologics (TOVX) and 9 Meters Biopharma (NMTR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2324057712","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2324057712?lang=en_us&edition=fundamental","pubTime":"2023-04-01 00:10","pubTimestamp":1680279019,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-theriva-biologics-tovx-and-9-meters-biopharma-nmtr?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-theriva-biologics-tovx-and-9-meters-biopharma-nmtr?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TOVX","BK4007","NMTR"],"gpt_icon":0},{"id":"2322262303","title":"9 Meters Biopharma Inc As Of Dec 31 Had Total Cash And Cash Equivalents Of About $29.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2322262303","media":"T-Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2322262303?lang=en_us&edition=fundamental","pubTime":"2023-03-28 22:54","pubTimestamp":1680015264,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.trkd.thomsonreuters.com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","LABP","BK4007","BK4139","LHDX","NMTR","ONTF","SANA","BK4082","TSS","APR","CGEM"],"gpt_icon":0},{"id":"2322503892","title":"9 Meters Biopharma Provides Business Update and Reports Financial Results for Fourth Quarter and Full Year 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2322503892","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2322503892?lang=en_us&edition=fundamental","pubTime":"2023-03-28 20:00","pubTimestamp":1680004800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/RCXeILW97jxa_piDrfIGzw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/efbf6a5a2f6d32c4de3ffe8ec60d7b94","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/RCXeILW97jxa_piDrfIGzw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/efbf6a5a2f6d32c4de3ffe8ec60d7b94"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/9-meters-biopharma-provides-business-120000603.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4191","PS","NMTR","CRCT","WT","BK4007","TERN","BK4172","SBS","BK4539"],"gpt_icon":0},{"id":"2320633540","title":"9 Meters Biopharma Cut to Hold From Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2320633540","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2320633540?lang=en_us&edition=fundamental","pubTime":"2023-03-20 20:03","pubTimestamp":1679313780,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMTR","BK4007"],"gpt_icon":0},{"id":"2320638623","title":"9 Meters downgraded to hold from buy at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2320638623","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2320638623?lang=en_us&edition=fundamental","pubTime":"2023-03-20 19:55","pubTimestamp":1679313300,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMTR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.innovatebiopharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.0704},{"period":"6month","weight":0.1207},{"period":"1year","weight":0.3195},{"period":"ytd","weight":0.2483}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Innovate Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company's lead product candidate is INN-202 that has completed Phase IIb clinical trial for the treatment of celiac disease. It also develops INN-108, which has completed Phase I clinical trial to treat mild-to-moderate ulcerative colitis; INN-217 for the treatment of non-alcoholic steatohepatitis and microbiome; and INN-289 to treat crohn's disease, as well as product for the treatment of alcoholic steatohepatitis (ASH). In addition, the company holds rights for INN-329, a formulation of secretin that is used to enhance visualization in magnetic resonance cholangiopancreatography procedures that is in Phase III clinical trial. The company has a research collaboration with Massachusetts General Hospital for the treatment of ASH. Innovate Biopharmaceuticals, Inc. is based in Raleigh, North Carolina.","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.176506},{"month":2,"riseRate":0.285714,"avgChangeRate":1.05034},{"month":3,"riseRate":0.285714,"avgChangeRate":0.497136},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.132332},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.163793},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.004783},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.256907},{"month":8,"riseRate":0.714286,"avgChangeRate":0.140425},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.030028},{"month":10,"riseRate":0,"avgChangeRate":-0.234451},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.024464},{"month":12,"riseRate":0.142857,"avgChangeRate":-0.103694}],"exchange":"NASDAQ","name":"9 Meters Biopharma Inc.","nameEN":"9 Meters Biopharma Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"9 Meters Biopharma Inc.(NMTR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest 9 Meters Biopharma Inc.(NMTR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"9 Meters Biopharma Inc.,NMTR,9 Meters Biopharma Inc.股票,9 Meters Biopharma Inc.股票老虎,9 Meters Biopharma Inc.股票老虎国际,9 Meters Biopharma Inc.行情,9 Meters Biopharma Inc.股票行情,9 Meters Biopharma Inc.股价,9 Meters Biopharma Inc.股市,9 Meters Biopharma Inc.股票价格,9 Meters Biopharma Inc.股票交易,9 Meters Biopharma Inc.股票购买,9 Meters Biopharma Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"9 Meters Biopharma Inc.(NMTR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest 9 Meters Biopharma Inc.(NMTR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction